`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MODERNA TI-IERAPEUTICS, INC,
`
`Petitioner,
`
`V.
`
`PROTIVA BIOTHERAPEUTICS, INC.,
`
`Patent Owner.
`
`U.S. Patent No. 9,364,435
`
`PETITIONER’S POWER OF ATTORNEY
`
`Mail Stop: PATENT BOARD
`Patent Trial and Appeal Board
`U.S. Patent & Trademark Office
`
`PO. BOX 1450
`
`Alexandria, VA 22313-1450
`
`
`
`US. Patent No. 9,364,435
`
`Pursuant to 37 CPR. 42.10(b), Petitioner Moderna Therapeutics, Inc.
`
`hereby appoints Michael R. Fleming as lead counsel, and Crawford Maclain
`
`Wells and Alan Heinrich as back-up counsel, as well as the practitioners
`
`associated with Irell & Manella LLP’S Customer No. 29000, to transact
`
`business in the United States Patent and Trademark Office associated with the
`
`above-captioned Inter Partes Review of US. Patent No. 9,364,435.
`
`LEAD COUNSEL
`
`BACK-UP COUNSEL
`
`Michael Fleming (Reg. No. 67,933) Crawford Maclain Wells (Reg. No. 48,991)
`Irell & Manella LLP
`Irell & Manella LLP
`
`
`1800 Avenue of the Stars, Suite 900
`
`Los Angeles, CA 90067
`
`Telephone: (310) 203-7565
`Facsimile: (310) 556-5365
`
`
`mwells@irell.com
`
`
` Alan Heinrich
`Irell & Manella LLP
`
`1800 Avenue of the Stars, Suite 900
`
`
`
`
`
`
`
`
`
`1800 Avenue of the Stars, Suite 900
`Los Angeles, CA 90067
`Telephone: (310) 277—1010
`Facsimile: (310) 203-7199
`mfleming@,irell.com
`ModernaIPR@,irell.com
`
`
`
`
`
`
`
`
`Los Angeles, CA 90067
`Telephone: (310) 203-7958
`Facsimile: (310) 556-5227
`aheinrich@irell.com
`
`
`
`US. Patent No. 9,364,435
`
`The individual signing below has the authority to execute this document
`
`on behalf of Moderna Therapeutics, Inc.
`
` Dated:
`
`(Mew K 1 7.0m;
`
`By:
`
`Stéphane Bance
`Chief Executive Officer
`
`Moderna Therapeutics, Inc.
`
`